Abstract

Screening for liver cancer: The good, the bad, and the ugly.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Association of cancer prevention awareness with liver cancer screening participation rates among a high-risk population: results from rural Anhui Province.
Zhirong Liu ... Yili Lyu
Chinese medical journal | VOL. 135
Zhirong Liu, et. al.Zhirong Liu ... Yili Lyu
22 Oct 2021
Low-abundance proteins-based label-free SERS approach for high precision detection of liver cancer with different stages
Xingen Gao ... Kecan Lin
Analytica Chimica Acta | VOL. 1304
Xingen Gao, et. al.Xingen Gao ... Kecan Lin
21 Mar 2024
Disparities in Liver Cancer Screening Among People with Disabilities: A National Database Study in Korea
Kyungdo Han ... Jong Heon Park
SSRN Electronic Journal | VOL. -
Kyungdo Han, et. al.Kyungdo Han ... Jong Heon Park
20 Jan 2020
Access to liver cancer screening and surveillance in populations in China: an exploratory analysis
...
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi | VOL. 43
, et. al. ...
10 Jun 2022
View more papers

More From: Hepatology (Baltimore, Md.)

Paper Title
Journal
Date
Author
Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study.
Stanislas Pol ... Joseph S Doyle
Hepatology (Baltimore, Md.) | VOL. -
Stanislas Pol, et. al.Stanislas Pol ... Joseph S Doyle
20 May 2024
Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease.
Takuma Nakatsuka ... Kazuhiko Koike
Hepatology (Baltimore, Md.) | VOL. -
Takuma Nakatsuka, et. al.Takuma Nakatsuka ... Kazuhiko Koike
20 May 2024
The obstacle is the way: Finding a path to hepatitis C elimination.
Vincent Lo Re ... Andrew Arohnson
Hepatology (Baltimore, Md.) | VOL. -
Vincent Lo Re, et. al.Vincent Lo Re ... Andrew Arohnson
16 May 2024
Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure.
Rita Feio-Azevedo ... Schalk Van Der Merwe
Hepatology (Baltimore, Md.) | VOL. -
Rita Feio-Azevedo, et. al.Rita Feio-Azevedo ... Schalk Van Der Merwe
16 May 2024
View more papers